Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Gretchen Kiser, PhD

    SchoolUCSF Chancellor/EVC/FAS
    DepartmentVice Chanc Research
    Address600 16th Street
    San Francisco CA 94158
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of ArizonaPhDMolecular and Cellular Biology1994
      University of California Los AngelesBSBiology

      Collapse Overview 
      Collapse Overview
      Dr. Gretchen Kiser is the Director of the Research Development Office (RDO) at the University of California San Francisco. In this role, she supports institutional research goals and strategic research initiatives broadly, leading a professional team: that employs innovative team science methods toward fostering development of collaborative, multi-disciplinary research teams and facilitating development of large, complex multi-investigator research proposals, and that manages the strategic distribution of intramural research funds and the selection of campus limited submission funding opportunity nominees.
      Dr. Kiser has a diverse research background in genetics, genomics, and molecular biology, including several years in the biotech industry focused on genotyping and gene expression product development. While in industry, she also acquired expertise in Lean Six Sigma, a statistical measurement-based business management strategy. She combines her hands-on research experience with research and faculty development, team science, teaching, and technical writing experience.
      As the elected Vice President of the National Organization of Research Development Professionals (NORDP), she is recognized as a leader in research development, an emerging field that sits at the nexus of research administration and research and encompasses the strategic development of new knowledge and knowledge mobilization. Team science is an essential element of research development and Dr. Kiser has developed and implemented a diverse set of methods and formats for team science, team-building, and conflict resolution all toward fostering innovative approaches and novel partnerships, facilitating greater team /program productivity, as well as increasing institutional competitiveness and capabilities in research funding. She has broad experience working in partnership with individual faculty members, teams of researchers, external cross-sector stakeholders and various institutional administrators to nurture the research programs and the institutional research enterprise generally.
      Dr. Kiser received her B.Sc. in Biology at UCLA, where her passion for academic research was sparked, and her Ph.D. in Molecular and Cellular Biology (Genetics minor), studying cell cycle regulation in the yeast genetics lab of Dr. Ted Weinert at the University of Arizona. She then went on to a post-doctoral fellowship at the Mayo Clinic in the protein structure/function lab of Dr. John Riordan.

      Collapse ORNG Applications 
      Collapse Websites
      Collapse In The News
      Collapse Twitter

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Miller RM, Kiser GL, Kaysser-Kranich T, Casaceli C, Colla E, Lee MK, Palaniappan C, Federoff HJ. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD. Exp Neurol. 2007 Mar; 204(1):421-32.
        View in: PubMed
      2. Thompson KL, Rosenzweig BA, Pine PS, Retief J, Turpaz Y, Afshari CA, Hamadeh HK, Damore MA, Boedigheimer M, Blomme E, Ciurlionis R, Waring JF, Fuscoe JC, Paules R, Tucker CJ, Fare T, Coffey EM, He Y, Collins PJ, Jarnagin K, Fujimoto S, Ganter B, Kiser G, Kaysser-Kranich T, Sina J, Sistare FD. Use of a mixed tissue RNA design for performance assessments on multiple microarray formats. Nucleic Acids Res. 2005; 33(22):e187.
        View in: PubMed PMC1322274
      3. Baker SC, Bauer SR, Beyer RP, Brenton JD, Bromley B, Burrill J, Causton H, Conley MP, Elespuru R, Fero M, Foy C, Fuscoe J, Gao X, Gerhold DL, Gilles P, Goodsaid F, Guo X, Hackett J, Hockett RD, Ikonomi P, Irizarry RA, Kawasaki ES, Kaysser-Kranich T, Kerr K, Kiser G, Koch WH, Lee KY, Liu C, Liu ZL, Lucas A, Manohar CF, Miyada G, Modrusan Z, Parkes H, Puri RK, Reid L, Ryder TB, Salit M, Samaha RR, Scherf U, Sendera TJ, Setterquist RA, Shi L, Shippy R, Soriano JV, Wagar EA, Warrington JA, Williams M, Wilmer F, Wilson M, Wolber PK, Wu X, Zadro R. The External RNA Controls Consortium: a progress report. Nat Methods. 2005 Oct; 2(10):731-4.
        View in: PubMed
      4. Miller RM, Kiser GL, Kaysser-Kranich TM, Lockner RJ, Palaniappan C, Federoff HJ. Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease. Neurobiol Dis. 2006 Feb; 21(2):305-13.
        View in: PubMed
      5. Miller RM, Chen LL, Kiser GL, Giesler TL, Kaysser-Kranich TM, Palaniappan C, Federoff HJ. Temporal evolution of mouse striatal gene expression following MPTP injury. Neurobiol Aging. 2005 May; 26(5):765-75.
        View in: PubMed
      6. Thomas N, Kenrick M, Giesler T, Kiser G, Tinkler H, Stubbs S. Characterization and gene expression profiling of a stable cell line expressing a cell cycle GFP sensor. Cell Cycle. 2005 Jan; 4(1):191-5.
        View in: PubMed
      7. Miller RM, Callahan LM, Casaceli C, Chen L, Kiser GL, Chui B, Kaysser-Kranich TM, Sendera TJ, Palaniappan C, Federoff HJ. Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra. J Neurosci. 2004 Aug 25; 24(34):7445-54.
        View in: PubMed
      8. Kiser GL, Gentzsch M, Kloser AK, Balzi E, Wolf DH, Goffeau A, Riordan JR. Expression and degradation of the cystic fibrosis transmembrane conductance regulator in Saccharomyces cerevisiae. Arch Biochem Biophys. 2001 Jun 15; 390(2):195-205.
        View in: PubMed
      9. Chang XB, Kartner N, Seibert FS, Aleksandrov AA, Kloser AW, Kiser GL, Riordan JR. Heterologous expression systems for study of cystic fibrosis transmembrane conductance regulator. Methods Enzymol. 1998; 292:616-29.
        View in: PubMed
      10. Kunzelmann K, Kiser GL, Schreiber R, Riordan JR. Inhibition of epithelial Na+ currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator. FEBS Lett. 1997 Jan 6; 400(3):341-4.
        View in: PubMed
      11. Kiser GL, Weinert TA. Distinct roles of yeast MEC and RAD checkpoint genes in transcriptional induction after DNA damage and implications for function. Mol Biol Cell. 1996 May; 7(5):703-18.
        View in: PubMed PMC275924
      12. Kiser GL, Weinert TA. GUF1, a gene encoding a novel evolutionarily conserved GTPase in budding yeast. Yeast. 1995 Oct; 11(13):1311-6.
        View in: PubMed
      13. Wang K, Klotz JL, Kiser G, Bristol G, Hays E, Lai E, Gese E, Kronenberg M, Hood L. Organization of the V gene segments in mouse T-cell antigen receptor alpha/delta locus. Genomics. 1994 Apr; 20(3):419-28.
        View in: PubMed
      14. Weinert TA, Kiser GL, Hartwell LH. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev. 1994 Mar 15; 8(6):652-65.
        View in: PubMed
      15. Klotz JL, Barth RK, Kiser GL, Hood LE, Kronenberg M. Restriction fragment length polymorphisms of the mouse T-cell receptor gene families. Immunogenetics. 1989; 29(3):191-201.
        View in: PubMed
      16. Klotz JL, Kiser GL, Kronenberg M. Molecular and serological diversity of anti-DNA autoantibodies from NZB and (NZB X NZW) F1 mice. Immunol Lett. 1988 Dec; 19(4):341-9.
        View in: PubMed
      Back to TOP